Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress

Frontiers in Cellular Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Zamarripa, David Arredondo ^a   Díaz Lezama, Nundehui ^a   García, Rodrigo Meléndez ^a   Balderas, Jesús Chávez ^a   Adán, Norma ^a   Ledesma Colunga, Maria G ^a   Arnold, Edith ^a   Clapp, Carmen ^a   Thebault, Stéphanie ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

16K prolactin; Blood retina barrier; Diabetes; Nitric oxide; Oxidative stress; Reactive oxygen species; Retinal pigment epithelium; Vasoinhibins

Indexed keywords

BRADYKININ; INHIBIN; UNCLASSIFIED DRUG; VASOINHIBIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CONFOCAL LASER MICROSCOPY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; RAT; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 84908241656     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00333     Document Type: Article

References (77)

1. Abdouh, M., Khanjari, A., Abdelazziz, N., Ongali, B., Couture, R., and Hassessian, H. M. (2003). Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat. Br. J. Pharmacol. 140, 33-40. doi: 10.1038/sj.bjp.0705210
2. Abdouh, M., Talbot, S., Couture, R., and Hassessian, H. M. (2008). Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors. Br. J. Pharmacol. 154, 136-143. doi: 10.1038/bjp.2008.48
3. Adan, N., Guzman-Morales, J., Ledesma-Colunga, M. G., Perales-Canales, S. I., Quintanar-Stephano, A., Lopez-Barrera, F., et al. (2013). Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J. Clin. Invest. 123, 3902-3913. doi: 10.1172/JCI69485
4. Aranda, J., Rivera, J. C., Jeziorski, M. C., Riesgo-Escovar, J., Nava, G., Lopez-Barrera, F., et al. (2005). Prolactins are natural inhibitors of angiogenesis in the retina. Invest. Ophthalmol. Vis. Sci. 46, 2947-2953. doi: 10.1167/iovs.05-0173
5. Arnold, E., Thebault, S., Baeza-Cruz, G., Arredondo Zamarripa, D., Adan, N., Quintanar-Stephano, A., et al. (2014). The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration. J. Neurosci. 34, 1868-1878. doi: 10.1523/JNEUROSCI.2452-13.2014
6. Bae, S. W., Kim, H. S., Cha, Y. N., Park, Y. S., Jo, S. A., and Jo, I. (2003). Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem. Biophys. Res. Commun. 306, 981-987. doi: 10.1016/S0006-291X(03)01086-6
7. Banumathi, E., Sheikpranbabu, S., Haribalaganesh, R., and Gurunathan, S. (2010). PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels. Exp. Eye Res. 90, 89-96. doi: 10.1016/j.exer.2009.09.014
8. Cai, H., Liu, D., and Garcia, J. G. (2008). CaM Kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc. Res. 77, 30-34. doi: 10.1093/cvr/cvm010
9. Cajero-Juarez, M., Avila, B., Ochoa, A., Garrido-Guerrero, E., Varela-Echavarria, A., Martinez De La Escalera, G., et al. (2002). Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium. Eur. J. Cell Biol. 81, 1-8. doi: 10.1078/0171-9335-00213
10. Charest-Morin, X., Roy, C., Fortin, E. J., Bouthillier, J., and Marceau, F. (2014). Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists. Front. Pharmacol. 5:32. doi: 10.3389/fphar.2014.00032
11. Clapp, C., Aranda, J., Gonzalez, C., Jeziorski, M. C., and Martinez De La Escalera, G. (2006). Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol. Metab. 17, 301-307. doi: 10.1016/j.tem.2006.08.002
12. Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delure, F., and Weiner, R. I. (1993). The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292-1299.
13. Clermont, A., Chilcote, T. J., Kita, T., Liu, J., Riva, P., Sinha, S., et al. (2011). Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats. Diabetes 60, 1590-1598. doi: 10.2337/db10-1260
14. Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G., and Franceschi, C. (1993). A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197, 40-45. doi: 10.1006/bbrc.1993.2438
15. De Bock, M., Wang, N., Decrock, E., Bol, M., Gadicherla, A. K., Culot, M., et al. (2013). Endothelial calcium dynamics, connexin channels and blood-brain barrier function. Prog. Neurobiol. 108, 1-20. doi: 10.1016/j.pneurobio.2013.06.001
16. Doctrow, S. R., Abelleira, S. M., Curry, L. A., Heller-Harrison, R., Kozarich, J. W., Malfroy, B., et al. (1994). The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. J. Pharmacol. Exp. Ther. 271, 229-237.
17. Dou, G., Sreekumar, P. G., Spee, C., He, S., Ryan, S. J., Kannan, R., et al. (2012). Deficiency of alphaB crystallin augments ER stress-induced apoptosis by enhancing mitochondrial dysfunction. Free Radic. Biol. Med. 53, 1111-1122. doi: 10.1016/j.freeradbiomed.2012.06.042
18. Dudek, S. M., and Garcia, J. G. (2001). Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. (1985) 91, 1487-1500.
19. Dunn, K., Aotaki-Keen, A. E., Putkey, F. R., and Hjelmeland, L. M. (1996). ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62, 155-169. doi: 10.1006/exer.1996.0020
20. Easton, A. S., and Abbott, N. J. (2002). Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier. Brain Res. 953, 157-169. doi: 10.1016/S0006-8993(02)03281-X
21. Fischer, A. J., and Stell, W. K. (1999). Nitric oxide synthase-containing cells in the retina, pigmented epithelium, choroid, and sclera of the chick eye. J. Comp. Neurol. 405, 1-14.
22. Fischer, S., Wiesnet, M., Renz, D., and Schaper, W. (2005). H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur. J. Cell Biol. 84, 687-697. doi: 10.1016/j.ejcb.2005.03.002
23. Fong, P., Stafforini, D. M., Brown, N. J., and Pretorius, M. (2010). Increased blood flow induces oxidative stress through an endothelium- and nitric oxide-independent mechanism. Free Radic. Biol. Med. 49, 301-305. doi: 10.1016/j.freeradbiomed.2010.04.023
24. Frey, T., and Antonetti, D. A. (2011). Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid. Redox Signal. 15, 1271-1284. doi: 10.1089/ars.2011.3906
25. Galfione, M., Luo, W., Kim, J., Hawke, D., Kobayashi, R., Clapp, C., et al. (2003). Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr. Purif. 28, 252-258. doi: 10.1016/S1046-5928(02)00639-3
26. Gao, B. B., Clermont, A., Rook, S., Fonda, S. J., Srinivasan, V. J., Wojtkowski, M., et al. (2007). Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 13, 181-188. doi: 10.1038/nm1534
27. Garcia, C., Aranda, J., Arnold, E., Thebault, S., Macotela, Y., Lopez-Casillas, F., et al. (2008). Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J. Clin. Invest. 118, 2291-2300. doi: 10.1172/JCI34508
28. Gardner, T. W., Antonetti, D. A., Barber, A. J., Lanoue, K. F., and Levison, S. W. (2002). Diabetic retinopathy: more than meets the eye. Surv. Ophthalmol. 47(Suppl. 2), S253-S262. doi: 10.1016/S0039-6257(02)00387-9
29. Gera, L., Bawolak, M. T., Roy, C., Lodge, R., and Marceau, F. (2011). Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme. J. Pharmacol. Exp. Ther. 337, 33-41. doi: 10.1124/jpet.110.177147
30. Goldstein, I. M., Ostwald, P., and Roth, S. (1996). Nitric oxide: a review of its role in retinal function and disease. Vision Res. 36, 2979-2994. doi: 10.1016/0042-6989(96)00017-X
31. Gonzalez, C., Corbacho, A. M., Eiserich, J. P., Garcia, C., Lopez-Barrera, F., Morales-Tlalpan, V., et al. (2004). 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145, 5714-5722. doi: 10.1210/en.2004-0647
32. Guo, L., Salt, T. E., Luong, V., Wood, N., Cheung, W., Maass, A., et al. (2007). Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. U.S.A. 104, 13444-13449. doi: 10.1073/pnas.0703707104
33. Han, E. D., Macfarlane, R. C., Mulligan, A. N., Scafidi, J., and Davis, A. E. 3rd. (2002). Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J. Clin. Invest. 109, 1057-1063. doi: 10.1172/JCI200214211
34. Harford-Wright, E., Lewis, K. M., and Vink, R. (2011). Towards drug discovery for brain tumours: interaction of kinins and tumours at the blood brain barrier interface. Recent Pat. CNS Drug Discov. 6, 31-40. doi: 10.2174/157488911794079118
35. Ho, T. C., Yang, Y. C., Cheng, H. C., Wu, A. C., Chen, S. L., and Tsao, Y. P. (2006). Pigment epithelium-derived factor protects retinal pigment epithelium from oxidant-mediated barrier dysfunction. Biochem. Biophys. Res. Commun. 342, 372-378. doi: 10.1016/j.bbrc.2006.01.164
36. Kayashima, Y., Smithies, O., and Kakoki, M. (2012). The kallikrein-kinin system and oxidative stress. Curr. Opin. Nephrol. Hypertens. 21, 92-96. doi: 10.1097/MNH.0b013e32834d54b1
37. Kim, J. H., Lee, S. J., Kim, K. W., and Yu, Y. S. (2012). Oxidized low density lipoprotein-induced senescence of retinal pigment epithelial cells is followed by outer blood-retinal barrier dysfunction. Int. J. Biochem. Cell Biol. 44, 808-814. doi: 10.1016/j.biocel.2012.02.005
38. Klaassen, I., Van Noorden, C. J., and Schlingemann, R. O. (2013). Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog. Retin. Eye Res. 34, 19-48. doi: 10.1016/j.preteyeres.2013.02.001
39. Leeb-Lundberg, L. M., Marceau, F., Muller-Esterl, W., Pettibone, D. J., and Zuraw, B. L. (2005). International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77. doi: 10.1124/pr.57.1.2
40. Lim, S. K., Han, H. J., Kim, K. Y., and Park, S. H. (2009). Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells. J. Cell. Physiol. 221, 677-687. doi: 10.1002/jcp.21906
41. Lim, S. K., Park, M. J., Jung, H. K., Park, A. Y., Kim, D. I., Kim, J. C., et al. (2008). Bradykinin stimulates glutamate uptake via both B1R and B2R activation in a human retinal pigment epithelial cells. Life Sci. 83, 761-770. doi: 10.1016/j.lfs.2008.09.014
42. Ling-Ling Zhao, J.-L. Q., Dan-Ni, C., and Han-Ben, N. (2009). Layered-resolved autofluorescence imaging of photoreceptors using two-photon excitation. J. Biomed. Sci. Eng. 2, 3. doi: 10.4236/jbise.2009.25052
43. Liu, J., and Feener, E. P. (2013). Plasma kallikrein-kinin system and diabetic retinopathy. Biol. Chem. 394, 319-328. doi: 10.1515/hsz-2012-0316
44. Ma, J. X., Song, Q., Hatcher, H. C., Crouch, R. K., Chao, L., and Chao, J. (1996). Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp. Eye Res. 63, 19-26. doi: 10.1006/exer.1996.0087
45. Marceau, F., and Regoli, D. (2004). Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3, 845-852. doi: 10.1038/nrd1522
46. Mathis, S. A., Criscimagna, N. L., and Leeb-Lundberg, L. M. (1996). B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells. Mol. Pharmacol. 50, 128-139.
47. Miranda, S., Gonzalez-Rodriguez, A., Garcia-Ramirez, M., Revuelta-Cervantes, J., Hernandez, C., Simo, R., et al. (2012). Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J. Cell. Physiol. 227, 2352-2362. doi: 10.1002/jcp.22970
48. Miura, Y., and Roider, J. (2009). Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells. Graefes Arch. Clin. Exp. Ophthalmol. 247, 641-649. doi: 10.1007/s00417-009-1041-6
49. Munoz, C. M., Cotecchia, S., and Leeb-Lundberg, L. M. (1993). B2 kinin receptor-mediated internalization of bradykinin in DDT1 MF-2 smooth muscle cells is paralleled by sequestration of the occupied receptors. Arch. Biochem. Biophys. 301, 336-344. doi: 10.1006/abbi.1993.1153
50. Munoz, C. M., and Leeb-Lundberg, L. M. (1992). Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. J. Biol. Chem. 267, 303-309.
51. Nostramo, R., Tillinger, A., Serova, L., Kvetnansky, R., and Sabban, E. L. (2013). Bradykinin B2 receptor in the adrenal medulla of male rats and mice: glucocorticoid-dependent increase with immobilization stress. Endocrinology 154, 3729-3738. doi: 10.1210/en.2013-1406
52. Oldenburg, O., Qin, Q., Krieg, T., Yang, X. M., Philipp, S., Critz, S. D., et al. (2004). Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 286, H468-H476. doi: 10.1152/ajpheart.00360.2003
53. Phagoo, S. B., Poole, S., and Leeb-Lundberg, L. M. (1999). Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol. Pharmacol. 56, 325-333.
54. Phipps, J. A., Clermont, A. C., Sinha, S., Chilcote, T. J., Bursell, S. E., and Feener, E. P. (2009). Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension 53, 175-181. doi: 10.1161/HYPERTENSIONAHA.108.117663
55. Pouliot, M., Hetu, S., Lahjouji, K., Couture, R., and Vaucher, E. (2011). Modulation of retinal blood flow by kinin B(1) receptor in Streptozotocin-diabetic rats. Exp. Eye Res. 92, 482-489. doi: 10.1016/j.exer.2011.03.007
56. Pouliot, M., Talbot, S., Senecal, J., Dotigny, F., Vaucher, E., and Couture, R. (2012). Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS ONE 7:e33864. doi: 10.1371/journal.pone.0033864
57. Pricci, F., Leto, G., Amadio, L., Iacobini, C., Cordone, S., Catalano, S., et al. (2003). Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. Free Radic. Biol. Med. 35, 683-694. doi: 10.1016/S0891-5849(03)00401-5
58. Qin, S., and Rodrigues, G. A. (2010). Differential roles of AMPKalpha1 and AMPKalpha2 in regulating 4-HNE-induced RPE cell death and permeability. Exp. Eye Res. 91, 818-824. doi: 10.1016/j.exer.2010.10.007
59. Ramirez, M., Wu, Z., Moreno-Carranza, B., Jeziorski, M. C., Arnold, E., Diaz-Lezama, N., et al. (2011). Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability. Invest. Ophthalmol. Vis. Sci. 52, 8944-8950. doi: 10.1167/iovs.11-8190
60. Raslan, F., Schwarz, T., Meuth, S. G., Austinat, M., Bader, M., Renne, T., et al. (2010). Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J. Cereb. Blood Flow Metab. 30, 1477-1486. doi: 10.1038/jcbfm.2010.28
61. Rees, D. D., Palmer, R. M., Hodson, H. F., and Moncada, S. (1989). A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96, 418-424. doi: 10.1111/j.1476-5381.1989.tb11833.x
62. Revest, P. A., Abbott, N. J., and Gillespie, J. I. (1991). Receptor-mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain Res. 549, 159-161. doi: 10.1016/0006-8993(91)90614-2
63. Rosas-Hernandez, H., Cuevas, E., Lantz-Mcpeak, S. M., Ali, S. F., and Gonzalez, C. (2013). Prolactin protects against the methamphetamine-induced cerebral vascular toxicity. Curr. Neurovasc. Res. 10, 346-355. doi: 10.2174/15672026113109990031
64. Sainz, I. M., Pixley, R. A., and Colman, R. W. (2007). Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb. Haemost. 98, 77-83. doi: 10.1160/TH07-04-0250
65. Sheikpranbabu, S., Haribalaganesh, R., Lee, K. J., and Gurunathan, S. (2010). Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie 92, 1040-1051. doi: 10.1016/j.biochi.2010.05.004
66. Smith, A. J., Lewis, F. C., Aquila, I., Waring, C. D., Nocera, A., Agosti, V., et al. (2014). Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart. Nat. Protoc. 9, 1662-1681. doi: 10.1038/nprot.2014.113
67. Takeda, H., Kimura, Y., Higashida, H., and Yokoyama, S. (1999). Localization of B2 bradykinin receptor mRNA in the rat retina and sclerocornea. Immunopharmacology 45, 51-55. doi: 10.1016/S0162-3109(99)00057-0
68. Teshima, Y., Takahashi, N., Nishio, S., Saito, S., Kondo, H., Fukui, A., et al. (2014). Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ. J. 78, 300-306. doi: 10.1253/circj.CJ-13-1187
69. Thebault, S. (2011). Vasoinhibins prevent Bradykinin-stimulated endothelial cell proliferation by Inactivating eNOS via reduction of both intracellular Ca2+ levels and eNOS phosphorylation at Ser1179. Pharmaceuticals (Basel). 4, 1052-1069. doi: 10.3390/ph4071052
70. Wilkinson-Berka, J. L. (2004). Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr. Pharm. Des. 10, 3331-3348. doi: 10.2174/1381612043383142
71. Wohlfart, P., Dedio, J., Wirth, K., Scholkens, B. A., and Wiemer, G. (1997). Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species. J. Pharmacol. Exp. Ther. 280, 1109-1116.
72. Xu, Q., Qaum, T., and Adamis, A. P. (2001). Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest. Ophthalmol. Vis. Sci. 42, 789-794.
73. Yamagishi, S., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., et al. (2006). Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J. Biol. Chem. 281, 20213-20220. doi: 10.1074/jbc.M602110200
74. Yasuyoshi, H., Kashii, S., Zhang, S., Nishida, A., Yamauchi, T., Honda, Y., et al. (2000). Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons. Invest. Ophthalmol. Vis. Sci. 41, 2273-2278.
75. Zavodnik, I. B., Dremza, I. K., Cheshchevik, V. T., Lapshina, E. A., and Zamaraewa, M. (2013). Oxidative damage of rat liver mitochondria during exposure to t-butyl hydroperoxide. Role of Ca(2)(+) ions in oxidative processes. Life Sci. 92, 1110-1117. doi: 10.1016/j.lfs.2013.04.009
76. Zech, J. C., Pouvreau, I., Cotinet, A., Goureau, O., Le Varlet, B., and De Kozak, Y. (1998). Effect of cytokines and nitric oxide on tight junctions in cultured rat retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 39, 1600-1608.
77. Zheng, L., and Kern, T. S. (2009). Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front. Biosci. (Landmark Ed.) 14, 3974-3987. doi: 10.2741/3505